Research Article | Open Access
TRIPS AGREEMENT IN INDIA AND ITS POTENTIAL EFFECTS ON THE PHARMACEUTICAL SECTOR
BRIJ MOHAN DUTTA,
Pages: 497-506
Abstract
India is now one of the world's leading exporters of pharmaceuticals, having become pharmaceutically self-sufficient. Drugs with active product patents may no longer be exported or manufactured through reverse engineering. The Indian pharmaceutical business, however, has been expanding in the years after TRIPS went into effect. On the other side, some people are worried that the new patent legislation may decrease the availability of generic drugs and make it harder for Indians to get the healthcare they need. The Indian government places a high priority on ensuring its citizens have access to quality healthcare at reasonable costs. The issue of affordable drug availability is crucial not only for India, but for all economically developing countries, given that India is the largest provider of cheap generic pharmaceuticals. The government should strike a balance between protecting intellectual property and ensuring that people have access to medicines.
Keywords
Compulsory, Licensing, Access, Medicines, Intellectual, Property Protection, Pharmaceutical